Home/Filings/4/0001179110-19-012695
4//SEC Filing

Goss Michael L 4

Accession 0001179110-19-012695

CIK 0001412270other

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 9:00 PM ET

Size

25.6 KB

Accession

0001179110-19-012695

Insider Transaction Report

Form 4
Period: 2019-12-09
Goss Michael L
Acting Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock, $0.001 par value

    2019-12-09+2115,762 total
  • Exercise/Conversion

    Common Stock, $0.001 par value

    2019-12-09+2686,030 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-12-09211212 total
    Common Stock (211 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2019-12-093,86927,090 total
    Common Stock (3,869 underlying)
  • Exercise/Conversion

    Common Stock, $0.001 par value

    2019-12-09+4664,987 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-12-093021,510 total
    Common Stock (302 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2019-12-09466467 total
    Common Stock (466 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2019-12-092683,484 total
    Common Stock (268 underlying)
  • Exercise/Conversion

    Common Stock, $0.001 par value

    2019-12-09+2625,551 total
  • Exercise/Conversion

    Common Stock, $0.001 par value

    2019-12-09+3025,289 total
  • Exercise/Conversion

    Common Stock, $0.001 par value

    2019-12-09+3,8699,899 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-12-092622,364 total
    Common Stock (262 underlying)
Footnotes (7)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
  • [F2]The restricted stock units will vest as to 6.25% of the original grant on June 9, 2016 and at the end of each successive three month period thereafter until March 9, 2020, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
  • [F3]The restricted stock units will vest as to 6.25% of the original grant on June 9, 2017 and at the end of each successive three month period thereafter until March 9, 2021, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
  • [F4]The restricted stock units will vest as to 6.25% of the original grant on June 9, 2018 and at the end of each successive three month period thereafter until March 9, 2022, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
  • [F5]The restricted stock units will vest as to 50% of the original grant on March 9, 2019 and as to an additional 12.5% at the end of each successive three month period thereafter until March 9, 2020, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
  • [F6]The restricted stock units will vest as to 6.25% of the original grant on June 9, 2019 and at the end of each successive three month period thereafter until March 9, 2023, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
  • [F7]The restricted stock units will vest as to 12.5% of the original grant on September 9, 2019 and at the end of each successive three month period thereafter until June 9, 2021, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.

Issuer

Care.com Inc

CIK 0001412270

Entity typeother

Related Parties

1
  • filerCIK 0001783472

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 9:00 PM ET
Size
25.6 KB